De Novo Design and Asymmetric Synthesis of a <i>C</i>-1/2 Benzodioxin Fused Glycoside Analogue of Lincomycin
An <i>in silico</i> designed benzodioxin fused analogue of a des-(1-hydroxyethyl)-lincomycin analogue was synthesized in a <i>de novo</i> asymmetric fashion from an achiral acylfuran, a 4-(<i>n</i>-Pr)-<i>N</i>-methyl-proline, and catechol. The synthesis of the 6-amino-galactose portion of the lincomycin analogue necessitated the development of a novel stereospecific tandem Pd-glycosylation/1,4-addition reaction between catechol and an <i>N</i>-Cbz-protected 6-amino-pyranone with a Pd-π-allyl leaving group at the <i>C</i>-1 position. The desired <i>galacto</i>-stereochemistry was installed by a subsequent stereoselective ketone reduction, alcohol elimination, and diastereoselective dihydroxylation of the <i>C</i>-3/4 alkene.
Authors
- George A. O’Doherty (ORCID: https://orcid.org/0000-0002-1699-2249)
- James E. Kirby (ORCID: https://orcid.org/0000-0003-0392-4500)
- Ramachandra Reddy Donthiri (ORCID: https://orcid.org/0000-0002-9048-5317)
- Lucius Chiaraviglio (ORCID: https://orcid.org/0000-0002-2613-6614)
- Alhanouf Z. Aljahdali (ORCID: https://orcid.org/0000-0002-6319-9702)
- Ian Hicks
- Ryan Moradei
Institutions
- Northeastern University (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Hadassah Medical Center (IL)
- Universidad del Noreste (MX)
Publication Details
- Journal
- Organic Letters
- Published
- 2025-09-05
- DOI
- https://doi.org/10.1021/acs.orglett.5c03402
- Primary Topic
- Microbial Natural Products and Biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Massachusetts Life Sciences Center
- King Abdullah University of Science and Technology
- National Institutes of Health
- Division of Chemistry